Latest Breaking News On - Research professor batakrishna jana - Page 1 : comparemela.com

New anticancer treatment technology targets cancer cell lysosomes and overcomes drug resistance

A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST.

United statesSouth koreaJa hyoung ryuMegan craigDepartment of chemicalNational research foundation of koreaTechnology development programResearch professor batakrishna jana department of chemistryEngineering at korea universityDepartment of chemistryMinistry of scienceJournal of the american chemical societySeongeon jin korea institute of scienceProfessor ja hyoung ryuResearch professor batakrishna janaSeongeon jin

Peptide Assembly in Lysosomes Offers High Cancer Selectivity

Peptide Assembly in Lysosomes Offers High Cancer Selectivity
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesSeongeon jinJa hyoung ryuBatakrishna janaResearch professor batakrishna jana department of chemistrySeongeon jin korea institute of scienceEngineering at korea universityDepartment of chemistryMinistry of scienceDepartment of chemicalTechnology development programJournal of the american chemical societyNational research foundation of koreaProfessor ja hyoung ryuResearch professor batakrishna jana

New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance

New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesJa hyoung ryuBatakrishna janaJournal of the american chemical societySeongeon jin korea institute of scienceDepartment of chemistryResearch professor batakrishna jana department of chemistryAmerican chemical societyProfessor ja hyoung ryuResearch professor batakrishna janaSeongeon jinKorea instituteAmerican chemicalIntra lysosomal peptide assemblyHigh selectivity index

Intra-lysosomal peptide assembly for the high

A research team, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has developed a groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance.

South koreaUnited statesBatakrishna janaSeongeon jinJa hyoung ryuDepartment of chemicalResearch professor batakrishna jana department of chemistrySeongeon jin korea institute of scienceJournal of the american chemical societyMinistry of scienceNational research foundation of koreaEngineering at korea universityDepartment of chemistryTechnology development programProfessor ja hyoung ryuResearch professor batakrishna jana